Functional Cardiomyocytes Derived from Isl1 Cardiac Progenitors via Bmp4 Stimulation

Cagavi, Esra; Bartulos, Oscar; Suh, Carol Y.; Sun, Baonan; Yue, Zhichao; Jiang, Zhengxin; Yue, Lixia; Qyang, Yibing
December 2014
PLoS ONE;Dec2014, Vol. 9 Issue 12, p1
Academic Journal
As heart failure due to myocardial infarction remains a leading cause of morbidity worldwide, cell-based cardiac regenerative therapy using cardiac progenitor cells (CPCs) could provide a potential treatment for the repair of injured myocardium. As adult CPCs may have limitations regarding tissue accessibility and proliferative ability, CPCs derived from embryonic stem cells (ESCs) could serve as an unlimited source of cells with high proliferative ability. As one of the CPCs that can be derived from embryonic stem cells, Isl1 expressing cardiac progenitor cells (Isl1-CPCs) may serve as a valuable source of cells for cardiac repair due to their high cardiac differentiation potential and authentic cardiac origin. In order to generate an unlimited number of Isl1-CPCs, we used a previously established an ESC line that allows for isolation of Isl1-CPCs by green fluorescent protein (GFP) expression that is directed by the mef2c gene, specifically expressed in the Isl1 domain of the anterior heart field. To improve the efficiency of cardiac differentiation of Isl1-CPCs, we studied the role of Bmp4 in cardiogenesis of Isl1-CPCs. We show an inductive role of Bmp directly on cardiac progenitors and its enhancement on early cardiac differentiation of CPCs. Upon induction of Bmp4 to Isl1-CPCs during differentiation, the cTnT+ cardiomyocyte population was enhanced 2.8±0.4 fold for Bmp4 treated CPC cultures compared to that detected for vehicle treated cultures. Both Bmp4 treated and untreated cardiomyocytes exhibit proper electrophysiological and calcium signaling properties. In addition, we observed a significant increase in Tbx5 and Tbx20 expression in differentiation cultures treated with Bmp4 compared to the untreated control, suggesting a link between Bmp4 and Tbx genes which may contribute to the enhanced cardiac differentiation in Bmp4 treated cultures. Collectively these findings suggest a cardiomyogenic role for Bmp4 directly on a pure population of Isl1 expressing cardiac progenitors, which could lead to enhancement of cardiac differentiation and engraftment, holding a significant therapeutic value for cardiac repair in the future.


Related Articles

  • Pluripotent stem cells for cardiac regeneration: Overview of recent advances & emerging trends. Pawani, Harsha; Bhartiya, Deepa // Indian Journal of Medical Research;Feb2013, Vol. 137 Issue 2, p270 

    Cell based regenerative therapy has emerged as one of the most promising options of treatment for patients suffering from heart failure. Various adult stem cells types have undergone extensive clinical trials with limited success which is believed to be more of a cytokine effect rather than cell...

  • Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions. Cao, Nan; Liang, He; Huang, Jijun; Wang, Jia; Chen, Yixiong; Chen, Zhongyan; Yang, Huang-Tian // Cell Research;Sep2013, Vol. 23 Issue 9, p1119 

    Cardiovascular progenitor cells (CVPCs) derived from human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs), hold great promise for the study of cardiovascular development and cell-based therapy of heart diseases, but...

  • Cardiac Cell Therapies: The Next Generation. Choi, Yeong-Hoon; Saric, Tomo; Nasseri, Boris; Hühn, Stefan; Van Linthout, Sophie; Hetzer, Roland; Tschöpe, Carsten; Stamm, Christof // Cardiovascular Therapeutics;Feb2011, Vol. 29 Issue 1, p2 

    Although significant advances have been made in terms of pharmacological, catheter-based, and surgical palliation, heart failure remains a fatal disease. As a curative concept, regenerative medicine aims at the restoration of the physiologic cellular composition of diseased organs. So far,...

  • Kardiale Stamm- und Progenitorzelltherapie: Bereit für die Zukunft? Emmert, Maximilian Y.; Templin, Christian // Praxis (16618157);4/10/2013, Vol. 102 Issue 8, p465 

    Cardiovascular diseases represent the major cause of mortality in the western world. The concept of regenerative medicine has been repeatedly suggested to be an innovative approach to repair and regenerate the diseased myocardium after acute myocardial infarction and chronic ischemic...

  • Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro. Heng, Boon Chin; Haider, Husnain Kh; Sim, Eugene Kwang-Wei; Cao, Tong; Ng, Soon Chye // Cardiovascular Research;Apr2004, Vol. 62 Issue 1, p34 

    Most studies on stem cell transplantation therapy on myocardially infarcted animal models and phase-I human clinical trials have focused on the use of undifferentiated stem cells. There is a strong possibility that some degree of cardiomyogenic differentiation of stem cells in vitro prior to...

  • SSEA-4+ CD34- Cells in the Adult Human Heart Show the Molecular Characteristics of a Novel Cardiomyocyte Progenitor Population. Sandstedt, Joakim; Jonsson, Marianne; Vukusic, Kristina; Dellgren, Göran; Lindahl, anders; Jeppsson, anders; asp, Julia // Cells Tissues Organs;Dec2014, Vol. 199 Issue 2/3, p103 

    Stage-specific embryonic antigen (SSEA) expression is used to describe the differentiation state of an embryonic stem cell (ESC). In human ESCs, SSEA-3 and SSEA-4 are highly expressed in undifferentiated cells and downregulated upon differentiation. SSEA-4 has also been described as a marker for...

  • Transplantation of parthenogenetic embryonic stem cells ameliorates cardiac dysfunction and remodelling after myocardial infarction. Liu, Yi; Ye, Xiaoying; Mao, Lina; Cheng, Zhaokang; Yao, Xinpeng; Jia, Xiaohua; Mao, Duo; Ou, Lailiang; Li, Zongjin; Che, Yongzhe; Liu, Na; Steinhoff, Gustav; Liu, Lin; Kong, Deling // Cardiovascular Research;Feb2013, Vol. 97 Issue 2, p208 

    Aims Parthenogenetic embryonic stem cells (pESCs) derived from artificially activated oocytes without fertilization presumably raise minimal ethical concerns and may serve as attractive candidates for regenerative medicine. Here we investigated whether pESCs could repair myocardial infarction...

  • Irisin promotes cardiac progenitor cell‐induced myocardial repair and functional improvement in infarcted heart. Zhao, Yu Tina; Wang, Jianguo; Yano, Naohiro; Zhang, Ling X.; Wang, Hao; Zhang, Shouyan; Qin, Gangjian; Dubielecka, Patrycja M.; Zhuang, Shougang; Liu, Paul Y.; Chin, Y. Eugene; Zhao, Ting C. // Journal of Cellular Physiology;Feb2019, Vol. 234 Issue 2, p1671 

    Irisin, a newly identified hormone and cardiokine, is critical for modulating body metabolism. New evidence indicates that irisin protects the heart against myocardial ischemic injury. However, whether irisin enhances cardiac progenitor cell (CPC)‐induced cardiac repair remains unknown....

  • Hematopoietic cell differentiation from embryonic and induced pluripotent stem cells. Wai Feng Lim; Tomoko Inoue-Yokoo; Keai Sinn Tan; Lai, Mei I.; Daisuke Sugiyama // Stem Cell Research & Therapy;2013, Vol. 4 Issue 3, p1 

    Pluripotent stem cells, both embryonic stem cells and induced pluripotent stem cells, are undifferentiated cells that can self-renew and potentially differentiate into all hematopoietic lineages, such as hematopoietic stem cells (HSCs), hematopoietic progenitor cells and mature hematopoietic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics